グレード＆純度Moligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.10mM in DMSO
DO-264 is a selective and in vivo-active inhibitor of Abhydrolase Domain Containing 12 ( ABHD12 ), with an IC 50 of 11 nM.
In Vitro
DO-264 displays an IC 50 value of 11 nM (9.6 nM-13 nM). DO-264 blocks lyso-PS hydrolysis activities of recombinant mouse and human ABHD12 in transfected HEK293T cell lysates (DO-264 IC 50 values of ~30 and 90 nM against mouse and human ABHD12, respectively) and the ABHD12-dependent lyso-PS lipase activity of membrane lysates from mouse brain (IC 50 =2.8 nM, 2.4 nM-3.3 nM) and human THP-1 cells (IC 50 = 8.6 nM, 6.3 nM-12 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Mice treated with DO-264 display dose-dependent increases in brain lyso-PS and 20:4 PS content that are qualitatively similar to the changes observed in ABHD12 –/– mice. DO-264-treated mice, however, show minimal impairment in auditory function following four weeks of drug exposure. Both ABHD12 –/– and DO-264-treated mice display exacerbated immunopathology following infection with the lymphocytic choriomeningitis virus (LCMV) clone 13, resulting in severe inflammatory lung damage, heightened chemokine production, and, in some cases, death . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:IC50: 11 nM (ABHD12)
仕様
仕様と純度
Moligand™, 10mM in DMSO
生化学的・生理学的メカニズム
DO-264 is a selective and in vivo-active inhibitor of Abhydrolase Domain Containing 12 ( ABHD12 ), with an IC 50 of 11 nM.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
